Propranolol better than corticosteroids for infant hemangioma

08/16/2011 |

A retrospective study of 110 patients with infantile hemangioma found that propranolol achieved a higher clearance rate at a lower cost and with fewer side effects than corticosteriods. All of the patients given corticosteriods suffered adverse effects, leading to termination earlier than with propranolol, which had a 1% adverse event rate. "Until recently, the mainstay of treatment for infantile hemangiomas has been corticosteroids in various forms," but propranolol should be considered a first-line treatment, the investigators wrote in the study published in Archives of Dermatology.

View Full Article in: